| Effects of protein conformation, apparent solubility, and protein–protein interactions on the rates and mechanisms of aggregation for an IgG1Monoclonal antibody C Kalonia, V Toprani, R Toth, N Wahome, I Gabel, CR Middaugh, ... The Journal of Physical Chemistry B 120 (29), 7062-7075, 2016 | 63 | 2016 |
| Analytical comparability assessments of 5 recombinant CRM197 proteins from different manufacturers and expression systems JM Hickey, VM Toprani, K Kaur, RPN Mishra, A Goel, N Oganesyan, ... Journal of pharmaceutical sciences 107 (7), 1806-1819, 2018 | 39 | 2018 |
| A micro–polyethylene glycol precipitation assay as a relative solubility screening tool for monoclonal antibody design and formulation development VM Toprani, SB Joshi, LA Kueltzo, RM Schwartz, CR Middaugh, ... Journal of Pharmaceutical Sciences 105 (8), 2319-2327, 2016 | 36 | 2016 |
| Correlating the impact of well-defined oligosaccharide structures on physical stability profiles of IgG1-Fc glycoforms AS More, VM Toprani, SZ Okbazghi, JH Kim, SB Joshi, CR Middaugh, ... Journal of Pharmaceutical Sciences 105 (2), 588-601, 2016 | 32 | 2016 |
| Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant VM Toprani, N Sahni, JM Hickey, GA Robertson, CR Middaugh, SB Joshi, ... Vaccine 35 (41), 5471-5480, 2017 | 18 | 2017 |
| Structural characterization and physicochemical stability profile of a double mutant heat labile toxin protein based adjuvant VM Toprani, JM Hickey, N Sahni, RT Toth IV, GA Robertson, ... Journal of Pharmaceutical Sciences 106 (12), 3474-3485, 2017 | 9 | 2017 |
| Structural characterization and formulation development of a trivalent equine encephalitis virus-like particle vaccine candidate VM Toprani, Y Cheng, N Wahome, H Khasa, LA Kueltzo, RM Schwartz, ... Journal of Pharmaceutical Sciences 107 (10), 2544-2558, 2018 | 5 | 2018 |
| Sterile filtration of a multi‐serotype glycoconjugate vaccine drug product Z Du, K Gill, V Toprani, AL Zydney Biotechnology and bioengineering 120 (5), 1316-1322, 2023 | 2 | 2023 |
| Exploring a role for flow-induced aggregation assays in platform formulation optimisation for antibody-based proteins LF Willis, V Toprani, S Wijetunge, A Sievers, L Lin, J Williams, TJ Crowley, ... Journal of Pharmaceutical Sciences 113 (3), 625-636, 2024 | 1 | 2024 |
| Filtration of a multi‐serotype glycoconjugate vaccine drug product through sterilizing grade 0.2/0.22 µm pore size filters Z Du, S Qiu, K Gill, V Toprani, AL Zydney Biotechnology Journal 19 (2), 2300450, 2024 | | 2024 |
| TOWARDS A BETTER UNDERSTANDING OF VACCINE STABILITY AS APPLIED TO PHARMACEUTICAL DEVELOPMENT OF VARIOUS RECOMBINANT PROTEIN VACCINE CANDIDATES VM TOPRANI University of Kansas, 2018 | | 2018 |
